Zachary Soler to United States
This is a "connection" page, showing publications Zachary Soler has written about United States.
Connection Strength
0.795
-
American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery. Int Forum Allergy Rhinol. 2021 09; 11(9):1296-1307.
Score: 0.079
-
American Rhinologic Society Expert Practice Statements: methodology and approval process. Int Forum Allergy Rhinol. 2021 09; 11(9):1291-1295.
Score: 0.079
-
Olfactory cleft and sinus opacification differentially impact olfaction in chronic rhinosinusitis. Laryngoscope. 2020 10; 130(10):2311-2318.
Score: 0.070
-
Impact of chronic rhinosinusitis on sleep: a controlled clinical study. Int Forum Allergy Rhinol. 2019 01; 9(1):16-22.
Score: 0.065
-
Taste impairment in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2018 07; 8(7):783-789.
Score: 0.063
-
Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017 07; 7(7):734-740.
Score: 0.059
-
Depression-Specific Outcomes After Treatment of Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):370-6.
Score: 0.055
-
Depression in chronic rhinosinusitis: A controlled cohort study. Am J Rhinol Allergy. 2016 Mar-Apr; 30(2):128-33.
Score: 0.054
-
Chronic rhinosinusitis: Epidemiology and burden of disease. Am J Rhinol Allergy. 2016 Mar-Apr; 30(2):134-9.
Score: 0.054
-
Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis. Laryngoscope. 2016 Mar; 126(3):570-4.
Score: 0.053
-
Chronic rhinosinusitis, race, and ethnicity. Am J Rhinol Allergy. 2012 Mar-Apr; 26(2):110-6.
Score: 0.041
-
Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop. Int Forum Allergy Rhinol. 2020 09; 10(9):1037-1042.
Score: 0.018
-
Socioeconomic status impacts postoperative productivity loss and health utility changes in refractory chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019 09; 9(9):1000-1009.
Score: 0.017
-
A framework for quality measurement in the presurgical care of chronic rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society. Int Forum Allergy Rhinol. 2018 12; 8(12):1380-1388.
Score: 0.016
-
Effect of Continued Medical Therapy on Productivity Costs for Refractory Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg. 2015 Nov; 141(11):969-73.
Score: 0.013
-
Does comorbid obesity impact quality of life outcomes in patients undergoing endoscopic sinus surgery? Int Forum Allergy Rhinol. 2015 Dec; 5(12):1085-94.
Score: 0.013
-
Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management. Int Forum Allergy Rhinol. 2015 Jan; 5(1):36-45.
Score: 0.012
-
Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope. 2015 Jan; 125(1):25-32.
Score: 0.012
-
Hematopoietic stem cell transplantation and rhinosinusitis: the utility of screening sinus computed tomography. Laryngoscope. 2012 Dec; 122(12):2647-51.
Score: 0.011
-
Changing trends in sinus and septal surgery, 2007 to 2009. Int Forum Allergy Rhinol. 2012 Sep-Oct; 2(5):357-61.
Score: 0.010